338 related articles for article (PubMed ID: 34209954)
21. Construction of an 11-microRNA-based signature and a prognostic nomogram to predict the overall survival of head and neck squamous cell carcinoma patients.
Huang Y; Liu Z; Zhong L; Wen Y; Ye Q; Cao D; Li P; Liu Y
BMC Genomics; 2020 Oct; 21(1):691. PubMed ID: 33023466
[TBL] [Abstract][Full Text] [Related]
22. Screening key lncRNAs with diagnostic and prognostic value for head and neck squamous cell carcinoma based on machine learning and mRNA-lncRNA co-expression network analysis.
Hu Y; Guo G; Li J; Chen J; Tan P
Cancer Biomark; 2020; 27(2):195-206. PubMed ID: 31815689
[TBL] [Abstract][Full Text] [Related]
23. Multiple microRNA signature panel as promising potential for diagnosis and prognosis of head and neck cancer.
Subha ST; Chin JW; Cheah YK; Mohtarrudin N; Saidi HI
Mol Biol Rep; 2022 Feb; 49(2):1501-1511. PubMed ID: 34837627
[TBL] [Abstract][Full Text] [Related]
24. A robust six-miRNA prognostic signature for head and neck squamous cell carcinoma.
Zhao X; Cui L
J Cell Physiol; 2020 Nov; 235(11):8799-8811. PubMed ID: 32342519
[TBL] [Abstract][Full Text] [Related]
25. 18F-fluoro-deoxy-glucose-positron emission tomography/computed tomography in diagnosis of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Rohde M; Dyrvig AK; Johansen J; Sørensen JA; Gerke O; Nielsen AL; Høilund-Carlsen PF; Godballe C
Eur J Cancer; 2014 Sep; 50(13):2271-9. PubMed ID: 25011659
[TBL] [Abstract][Full Text] [Related]
26. A panel of circulating miRNAs as diagnostic biomarkers for screening multiple myeloma: a systematic review and meta-analysis.
Zhang L; Cao D; Tang L; Sun C; Hu Y
Int J Lab Hematol; 2016 Dec; 38(6):589-599. PubMed ID: 27870469
[TBL] [Abstract][Full Text] [Related]
27. Identification of microRNAs as novel biomarkers for detecting esophageal squamous cell carcinoma in Asians: a meta-analysis.
Wang Y; Wang Q; Zhang N; Ma H; Gu Y; Tang H; Xu Z; Gao Y
Tumour Biol; 2014 Nov; 35(11):11595-604. PubMed ID: 25135426
[TBL] [Abstract][Full Text] [Related]
28. The diagnostic performance of CT and MRI for detecting extranodal extension in patients with head and neck squamous cell carcinoma: a systematic review and diagnostic meta-analysis.
Park SI; Guenette JP; Suh CH; Hanna GJ; Chung SR; Baek JH; Lee JH; Choi YJ
Eur Radiol; 2021 Apr; 31(4):2048-2061. PubMed ID: 32949282
[TBL] [Abstract][Full Text] [Related]
29. Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part I: A Diagnostic Accuracy Meta-Analysis.
Rapado-González Ó; Martínez-Reglero C; Salgado-Barreira Á; Muinelo-Romay L; Muinelo-Lorenzo J; López-López R; Díaz-Lagares Á; Suárez-Cunqueiro MM
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34204396
[TBL] [Abstract][Full Text] [Related]
30. MiRNA-221/222 in thyroid cancer: A meta-analysis.
Liang L; Zheng X; Hu M; Cui Y; Zhong Q; Wang S; Huang F
Clin Chim Acta; 2018 Sep; 484():284-292. PubMed ID: 29894779
[TBL] [Abstract][Full Text] [Related]
31. Expression level and prospective mechanism of miRNA-99a-3p in head and neck squamous cell carcinoma based on miRNA-chip and miRNA-sequencing data in 1, 167 cases.
Wei GG; Guo WP; Tang ZY; Li SH; Wu HY; Zhang LC
Pathol Res Pract; 2019 May; 215(5):963-976. PubMed ID: 30904360
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of NI-RADS for prediction of head and neck squamous cell carcinoma: a systematic review and meta-analysis.
Li W; Sun Y; Shang W; Xu H; Zhang H; Lu F
Radiol Med; 2024 Jan; 129(1):70-79. PubMed ID: 37904037
[TBL] [Abstract][Full Text] [Related]
33. Circulating human papillomavirus DNA as a surveillance tool in head and neck squamous cell carcinoma: A systematic review and meta-analysis.
Jensen KK; Grønhøj C; Jensen DH; von Buchwald C
Clin Otolaryngol; 2018 Oct; 43(5):1242-1249. PubMed ID: 29763978
[TBL] [Abstract][Full Text] [Related]
34. The Association and Clinical Significance of CDKN2A Promoter Methylation in Head and Neck Squamous Cell Carcinoma: a Meta-Analysis.
Zhou C; Shen Z; Ye D; Li Q; Deng H; Liu H; Li J
Cell Physiol Biochem; 2018; 50(3):868-882. PubMed ID: 30355925
[TBL] [Abstract][Full Text] [Related]
35. Insights into the potential use of microRNAs as a novel class of biomarkers in esophageal cancer.
Wan J; Wu W; Che Y; Kang N; Zhang R
Dis Esophagus; 2016 Jul; 29(5):412-20. PubMed ID: 25789723
[TBL] [Abstract][Full Text] [Related]
36. The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis.
Dioguardi M; Spirito F; Sovereto D; Alovisi M; Aiuto R; Garcovich D; Crincoli V; Laino L; Cazzolla AP; Caloro GA; Di Cosola M; Ballini A; Lo Muzio L; Troiano G
Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564727
[TBL] [Abstract][Full Text] [Related]
37. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol.
Arantes LM; Laus AC; Melendez ME; de Carvalho AC; Sorroche BP; De Marchi PR; Evangelista AF; Scapulatempo-Neto C; de Souza Viana L; Carvalho AL
Oncotarget; 2017 Feb; 8(6):9911-9921. PubMed ID: 28039483
[TBL] [Abstract][Full Text] [Related]
38. The accuracy of Fiber-Optic Raman Spectroscopy in the detection and diagnosis of head and neck neoplasm
Chen W; Chen Y; Wu C; Zhang X; Huang X
PeerJ; 2023; 11():e16536. PubMed ID: 38099303
[TBL] [Abstract][Full Text] [Related]
39. Salivary microRNAs identified by small RNA sequencing as potential predictors of response to intensity-modulated radiotherapy in head and neck cancer patients.
Ahmad P; Slavik M; Trachtova K; Gablo NA; Kazda T; Gurin D; Smilek P; Horakova Z; Gal B; Hermanova M; Slampa P; Sana J; Slaby O
Cell Oncol (Dordr); 2020 Jun; 43(3):505-511. PubMed ID: 32266559
[TBL] [Abstract][Full Text] [Related]
40. Can blood and salivary biomarkers replace biopsy as a diagnostic tool?
Adam M
Evid Based Dent; 2022 Mar; 23(1):10-11. PubMed ID: 35338316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
